Chinmay Kumar Panda

20PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersProteins and peptidesMolecular targetsHaematologyCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Mar 05, 2026
Correction: High nuclear expression of DNMT1 in correlation with inactivation of TET1 portray worst prognosis among the cervical carcinoma patients: clinical implications.

Priyanka Dutta, Mukta Basu, Anup Roy

|Jan 03, 2026
Retraction Note: High nuclear expression of HIF1α, synergizing with inactivation of LIMD1 and VHL, portray worst prognosis among the bladder cancer patients: association with arsenic prevalence.

Mukta Basu, Amvrin Chatterjee, Balarko Chakraborty

|Dec 11, 2024
Retraction Note: Downregulation of Hyaluronic acid-CD44 signaling pathway in cervical cancer cell by natural polyphenols Plumbagin, Pongapin and Karanjin.

Rituparna Roy, Suvra Mandal, Jayanta Chakrabarti

|May 02, 2024
Retraction Note: Differential operation of MLH1/MSH2 and FANCD2 crosstalk in chemotolerant bladder carcinoma: a clinical and therapeutic intervening study.

Mukta Basu, Debalina Mukhopadhyay, Balarko Chakraborty

|Jan 22, 2024
High prevalence of CD44 and its ligand low molecular weight hyaluronan in plasma of HNSCC patients: clinical significance.

Rituparna Roy, Nilanjana Chatterjee, Md Sadi Khan

|Nov 27, 2023
Down-regulation of FA-BRCA Pathway in Cervical Carcinoma Gradually Reversed During the Development of Chemo-tolerance: Clinical Implications.

Priyanka Dutta, Debolina Pal, Farhin Sultana

Pageof 4

Frequent Collaborators

3 joint publications

Mukta Basu

3 joint publications

Dilip Kumar Pal

3 joint publications

Amlan Ghosh

1 joint publications

Subhamita Maitra